Phase I Clinical Study of MBS301 in Treatment of HER2 Positive Recurrent or Metastatic Malignant Solid Tumor
Clinical trial NCT03842085 · RECRUITING
Trial details
- NCT number
- NCT03842085
- Sponsor
- Beijing Mabworks Biotech Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-11
- Primary completion
- 2024-12-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.